improv
diagnost
tool
rapid
detect
quantit
subgroup
human
respiratori
syncyti
viru
rsv
need
aid
develop
evalu
novel
intervent
strategi
quantit
realtim
rtpcr
use
specif
lock
nucleic
acid
lna
probe
develop
identifi
rsv
distinguish
rsv
subgroup
b
rsv
lna
assay
rsv
subgroup
divers
relationship
viral
load
diseas
sever
confirm
rsv
infect
also
explor
archiv
respiratori
specimen
pediatr
patient
test
parallel
use
commerci
multiplex
seeplex
tm
rv
detect
kit
seegen
novel
rsv
lna
assay
lna
assay
demonstr
significantli
higher
sensit
seeplex
improv
overal
detect
rate
detect
limit
copiesml
observ
rsv
b
respect
rsv
detect
case
posit
rsv
b
novel
method
offer
rapid
quantit
highli
specif
sensit
approach
laboratori
diagnosi
rsv
improv
diagnost
tool
rapid
detect
quantit
subgroup
human
respiratori
syncyti
viru
rsv
need
aid
develop
evalu
novel
intervent
strategi
quantit
realtim
rtpcr
use
specif
lock
nucleic
acid
lna
probe
develop
identifi
rsv
distinguish
rsv
subgroup
b
rsv
lna
assay
rsv
subgroup
divers
relationship
viral
load
diseas
sever
confirm
rsv
infect
also
explor
archiv
respiratori
specimen
pediatr
patient
test
parallel
use
commerci
multiplex
seeplex
tm
rv
detect
kit
seegen
novel
rsv
lna
assay
lna
assay
demonstr
significantli
higher
sensit
seeplex
improv
overal
detect
rate
detect
limit
copiesml
observ
rsv
b
respect
rsv
detect
case
posit
rsv
b
novel
method
offer
rapid
quantit
highli
specif
sensit
approach
laboratori
diagnosi
rsv
human
respiratori
syncyti
viru
rsv
pneumoviru
member
subfamili
pneumovirina
within
famili
paramyxovirida
base
differ
antigen
nucleotid
sequenc
analysi
rsv
strain
classifi
two
major
antigen
subgroup
denot
rsv
rsv
b
sullend
rsv
major
caus
acut
respiratori
tract
infect
children
worldwid
nair
et
al
weber
et
al
respons
larg
proport
hospit
admiss
infanc
earli
childhood
mejia
et
al
vaccin
avail
treatment
limit
support
care
empey
et
al
rsv
also
frequent
caus
nosocomi
infect
may
significantli
impact
durat
stay
hospit
healthcar
cost
childhood
macartney
et
al
data
epidemiolog
molecular
virolog
characterist
rsv
isol
circul
southeast
asia
limit
diagnosi
rsv
infect
typic
perform
respiratori
sampl
use
viru
cultur
rapid
antigen
detect
test
molecular
assay
henrickson
realtim
revers
transcriptas
pcr
rtpcr
provid
rapid
sensit
tool
detect
rsv
compar
convent
techniqu
enabl
semi
quantit
viral
load
borg
et
al
dewhurstmaridor
et
al
nascimento
et
al
empey
et
al
falsey
et
al
falsey
et
al
henrickson
houben
et
al
hu
et
al
kuyper
et
al
mentel
et
al
perkin
et
al
van
de
pol
et
al
van
de
pol
et
al
van
elden
et
al
lock
nucleic
acid
lna
technolog
increas
thermal
stabil
probetarget
interact
improv
discrimin
differ
nucleic
acid
target
reynisson
et
al
n
gene
conserv
rsv
gene
across
known
genet
clade
also
express
abundantli
viral
replic
david
knipe
johnson
collin
reason
n
gene
chosen
target
novel
realtim
rtpcr
diagnost
tool
provid
quantit
viral
load
analysi
discrimin
rsv
b
within
singl
assay
quantit
assay
compar
commerci
convent
multiplex
pcr
method
seeplex
tm
rv
detect
kit
seegen
inc
seoul
korea
kim
et
al
roh
et
al
respiratori
sampl
studi
et
al
acut
respiratori
infect
children
hospit
tropic
diseas
ho
chi
minh
citi
vietnam
develop
valid
assay
report
well
initi
observ
regard
subgroup
divers
within
vietnames
rsv
strain
relationship
viral
load
diseas
sever
vietnames
patient
develop
evalu
novel
rsv
diagnost
respiratori
sampl
collect
store
part
studi
acut
respiratori
infect
among
children
hospit
tropic
diseas
ho
chi
minh
citi
vietnam
use
et
al
specimen
kept
c
maximum
h
aliquot
store
c
process
sampl
compris
nasopharyng
aspir
throat
swab
nasal
swab
collect
viral
transport
medium
repres
case
admit
pediatr
intens
care
unit
icu
well
pediatr
respiratori
ward
one
hundr
fortyon
sampl
patient
less
year
old
year
old
year
old
sampl
analyz
parallel
commerci
multiplex
seeplex
tm
rv
detect
kit
seegen
inc
seoul
korea
accord
manufactur
instruct
determin
presenc
respiratori
virus
human
rsv
subgroup
b
rsv
rsv
b
influenza
viru
infv
influenza
viru
b
infv
b
human
coronavirus
human
metapneumoviru
hmpv
parainfluenza
viru
human
rhinoviru
hrv
adenoviru
adv
kim
et
al
roh
et
al
newli
develop
rsv
lna
realtim
rtpcr
rna
extract
l
specimen
elut
l
easi
mag
system
marci
franc
intern
rnaviru
control
equin
arter
viru
eav
ad
sampl
prior
extract
standard
concentr
yield
ct
valu
previous
describ
scheltinga
et
al
rna
revers
transcrib
use
superscript
iii
revers
transcriptas
invitrogen
carlsbad
ca
usa
random
hexam
roch
mannheim
germani
l
reaction
mixtur
contain
l
extract
rna
rtbuffer
invitrogen
mm
dntp
roch
ng
random
hexam
mm
dtt
invitrogen
u
rnase
inhibitor
u
rt
superscript
iii
cdna
synthesi
perform
use
eppendorf
master
thermocycl
gradient
system
perkinelm
corpor
foster
citi
ca
usa
follow
condit
min
c
min
c
min
c
assay
design
detect
known
rsv
strain
differenti
rsv
subgroup
b
primer
select
use
primer
express
softwar
appli
biosystem
inc
foster
citi
ca
usa
dataset
gene
sequenc
avail
ncbi
databas
tabl
amplifi
bp
rsv
rsv
b
rsv
subgroup
b
differ
nucleotid
within
highli
conserv
region
n
gene
two
lna
probe
rsva
rsv
b
sigma
proligo
singapor
design
includ
three
lna
residu
site
rsv
c
g
rsv
b
choic
report
compat
quencher
base
biorad
guidelin
biorad
primer
probe
analyz
fals
prime
site
hybrid
secondari
structur
http
lnatoolscomhybrid
plasmid
contain
amplicon
rsv
rsv
b
clinic
strain
construct
use
posit
control
gener
standard
curv
quantit
briefli
target
cdna
amplifi
via
rtpcr
rsv
rsv
bposit
clinic
specimen
identifi
seeplex
tm
rv
detect
kit
clone
pcrii
topo
vector
transform
bacteri
strain
use
topa
ta
clone
kit
invitrogen
clone
screen
pcr
use
primer
confirm
sequenc
ceq
dtc
quick
start
kit
ceq
capillari
sequenc
beckman
coulter
inc
fullerton
ca
usa
quantit
plasmid
prepar
ngl
conduct
use
picogreen
dsdna
quantit
reagent
invitrogen
duplic
correspond
copi
number
target
cdna
plasmid
calcul
copiesml
serial
dilut
made
analysi
analyt
sensit
use
standard
curv
viral
load
quantit
viral
load
express
copi
per
ml
sampl
ctvalu
chosen
cutoff
valu
standard
posit
rsv
lna
assay
perform
dna
engin
peltier
thermocycl
chromo
realtim
pcr
system
detector
biorad
hercul
usa
total
volum
l
contain
ul
templat
cdna
u
hotstart
taq
invitrogen
pcr
buffer
mm
mgcl
mm
dntp
roch
primer
rsv
eav
probe
rsv
eav
probe
tabl
pcr
employ
follow
thermal
cycler
set
min
c
follow
cycl
c
min
c
neg
control
standard
includ
everi
assay
run
number
rsv
rna
transcript
copiesml
clinic
sampl
determin
base
standard
curv
ctvalu
chosen
cutoff
valu
sampl
posit
clinic
sampl
requir
ct
valu
eav
intern
control
consid
valid
potenti
interfer
primersprob
target
rsv
intern
control
eav
assess
run
serial
dilut
two
clinic
sampl
confirm
high
viral
load
rsv
rsv
b
data
shown
analyt
limit
detect
determin
use
six
dilut
control
plasmid
copiesml
rsv
copiesml
rsv
b
viral
load
clinic
sampl
assess
run
parallel
quantit
standard
sinc
concentr
target
cdna
plasmid
control
known
correspond
concentr
cdna
clinic
sampl
could
estim
sampl
test
posit
rsv
lna
seeplex
confirm
seminest
rtpcr
target
second
hypervari
region
rsv
g
gene
describ
previous
parveen
et
al
specif
assay
assess
presenc
nonrsv
virus
within
sampl
set
determin
seeplex
specif
assess
attempt
amplif
cultur
supernat
select
human
season
influenza
isol
anew
statist
comparison
seeplex
rtpcr
rsvlna
assay
perform
use
mcnemar
test
assay
variabl
quantifi
standard
deviat
sd
coeffici
variat
cv
ctvalu
five
dilut
control
analyt
limit
detect
determin
use
six
serial
dilut
control
plasmid
sextupl
detect
observ
concentr
rang
copiesml
rsv
copiesml
rsv
b
detect
rate
copiesml
rsv
copiesml
rsvb
signific
neg
linear
relationship
observ
copiesml
ct
valu
first
five
dilut
copiesml
rsv
adjust
r
copiesml
rsv
b
adjust
r
assess
analyt
intraand
interassay
reproduc
amplif
step
assay
ct
valu
compar
replic
five
serial
dilut
test
batch
tabl
differ
day
tabl
coeffici
variat
cv
analyt
intraassay
variabl
rsv
b
rang
respect
similarli
cv
analyt
interassay
variabl
rsv
b
rang
specif
assay
confirm
failur
amplifi
specimen
known
contain
respiratori
virus
detect
seeplex
assay
includ
influenza
virus
n
rhinoviru
n
human
coronaviru
n
human
metapneumoviru
n
parainfluenza
viru
n
adenoviru
n
addit
amplif
observ
cultur
supernat
contain
high
titer
influenza
virus
addit
sampl
posit
rsv
lna
assay
confirm
use
rsv
g
gene
rtpcr
parveen
et
al
none
sampl
neg
rsv
lna
assay
posit
seeplex
fluoresc
signal
eav
intern
control
detect
test
sampl
ct
valu
rang
viral
load
rsv
detect
sampl
rang
copiesml
median
valu
interquartil
rang
iqr
median
iqr
viral
load
posit
sampl
rsv
lna
assay
seeplex
kit
copiesml
sampl
posit
rsv
lna
assay
alon
median
iqr
viral
load
copiesml
signific
differ
observ
viral
load
rsv
posit
sampl
diagnos
assay
rsv
posit
sampl
rsv
lna
assay
mannwhitney
u
test
p
fig
among
rsv
posit
sampl
identifi
rsv
rsv
b
concord
subgroup
identif
rsv
lna
assay
seeplex
kit
associ
found
rsv
subgroup
diseas
sever
base
distribut
case
pediatr
intens
care
unit
icu
ward
similarli
signific
differ
observ
viral
load
rsv
subgroup
overal
total
patient
sever
present
pediatr
icu
admiss
rsv
posit
wherea
patient
ward
rsv
posit
fisher
exact
test
p
viral
load
nasal
pharyng
aspir
pediatr
icu
patient
significantli
higher
compar
case
median
iqr
viral
load
copiesml
pediatr
icu
rsv
posit
sampl
versu
posit
sampl
ward
mannwhitney
u
test
p
associ
valu
calcul
ct
valu
six
replic
concentr
sd
standard
deviat
cv
coeffici
variat
higher
age
lower
logvl
also
found
correl
p
among
rsv
posit
patient
younger
age
associ
sever
diseas
correl
p
dataset
adjust
age
differ
viral
load
sever
lost
statist
signific
data
shown
signific
differ
rsv
viral
load
observ
patient
singl
infect
versu
coinfect
patient
requir
oxygen
versu
patient
detect
seeplex
assay
reveal
overal
coinfect
level
includ
influenza
virus
n
parainfluenza
virus
n
coronavirus
n
adenoviru
n
human
metapneumoviru
n
rhinoviru
n
rsv
lna
assay
reveal
addit
rsv
posit
sampl
none
coinfect
preval
coinfect
rsv
posit
sampl
rsv
rsv
b
rsv
pathogen
detect
frequent
among
hospit
children
acut
respiratori
infect
prospect
studi
conduct
pediatr
icu
respiratori
ward
hospit
tropic
diseas
ho
chi
minh
citi
viet
nam
et
al
rapid
sensit
detect
rsv
import
instal
infect
control
measur
thu
prevent
nosocomi
spread
recogn
major
risk
pediatr
ward
macartney
et
al
sever
rtpcr
base
method
realtim
rtpcr
describ
rsv
detect
borg
et
al
dewhurstmaridor
et
al
nascimento
et
al
falsey
et
al
gueudin
et
al
hu
et
al
kuyper
et
al
kuyper
et
al
mentel
et
al
perkin
et
al
van
de
pol
et
al
van
de
pol
et
al
van
elden
et
al
improv
pcr
diagnost
tool
use
lna
probe
target
conserv
region
n
gene
develop
detect
distinguish
simultan
subgroup
b
quantifi
viral
rna
load
intern
control
viru
eav
ad
specimen
order
monitor
effici
rna
extract
revers
transcript
amplif
assay
exhibit
increas
diagnost
yield
compar
commerci
convent
multiplex
pcr
assay
seeplex
tm
rv
detect
kit
produc
diagnost
result
within
h
sampl
receipt
previou
studi
report
higher
sensit
pcr
method
target
n
gene
compar
method
target
gene
perkin
et
al
rohwedd
et
al
primer
probe
origin
design
base
avail
n
gene
sequenc
ncbi
genbank
includ
two
refer
strain
b
twentyfour
recent
submiss
n
gene
sequenc
cambodia
show
perfect
match
primer
probe
indic
primer
probe
theoret
could
detect
current
known
circul
strain
rsv
detect
rate
copiesml
rsv
copiesml
rsv
b
rang
previous
publish
method
use
dilut
seri
plasmid
dna
recalcul
assum
rt
effici
method
use
rna
transcript
rang
copiesml
borg
et
al
gueudin
et
al
kuyper
et
al
signific
linear
correl
ct
valu
copiesml
observ
level
viral
load
typic
found
clinic
specimen
addit
assay
exhibit
good
analyt
reproduc
evidenc
intraand
interassay
cv
rang
cv
report
diagnost
approach
base
copiesml
rang
borg
et
al
gueudin
et
al
kuyper
et
al
rsv
pathogenesi
multifactori
vari
collin
graham
relationship
diseas
sever
viral
load
rsv
subgroup
studi
associ
rsv
viral
load
diseas
sever
report
previous
buckingham
et
al
fodha
et
al
houben
et
al
sever
studi
definit
shown
neg
correl
rsv
viral
load
age
borg
et
al
gueudin
et
al
kuyper
et
al
result
current
studi
confirm
neg
correl
rsv
viral
load
age
signific
differ
viral
load
sever
nonsever
patient
defin
admiss
statu
pediatr
icu
versu
respiratori
ward
howev
dataset
adjust
age
differ
viral
load
sever
lost
statist
signific
previou
studi
also
suggest
possibl
differ
pathogen
rsv
b
campanini
et
al
gerna
et
al
kuyper
et
al
perkin
et
al
report
signific
differ
viral
load
sever
rsv
subgroup
variat
sampl
collect
may
also
affect
observ
viral
load
howev
sampl
collect
cohort
conduct
experienc
welltrain
hospit
personnel
use
standard
oper
procedur
conclus
novel
realtim
rsv
lna
assay
offer
rapid
specif
highli
reproduc
sensit
altern
commerci
multiplex
rtpcr
rsv
detect
addit
provid
quantit
subgroup
inform
use
epidemiolog
surveil
clinic
decisionmak
